Company · CIK 0001345099 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
MESOBLAST LTD · MESO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 AForm 4 → | Jul 9, 2026, 9:54 pm EDT | James Michael ObrienChief Financial Officer | 650,000 | — | — | 650,000 | — | late |